Clinical Trial Update: The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy [Phase 4]

View source ↗

Summary

Phase 4 exploratory trial assessing ramelteon for insomnia in patients with major depressive disorder; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Insomnia, Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2019-07-22